Marshall Wace North America’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-44,175
| Closed | -$4.02M | – | 1547 |
|
|
2020
Q4 | $4.02M | Buy |
+44,175
| New | +$4.02M | 0.02% | 588 |
|
|
2020
Q3 | – | Sell |
-131,496
| Closed | -$4.51M | – | 1289 |
|
|
2020
Q2 | $4.51M | Sell |
131,496
-299,464
| -69% | -$10.3M | 0.03% | 383 |
|
|
2020
Q1 | $9.57M | Buy |
430,960
+144,488
| +50% | +$3.21M | 0.07% | 227 |
|
|
2019
Q4 | $5.61M | Buy |
286,472
+257,231
| +880% | +$5.03M | 0.03% | 372 |
|
|
2019
Q3 | $454K | Buy |
+29,241
| New | +$454K | ﹤0.01% | 828 |
|